Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ftortiazinon + Maxipime in cUTI caused by P. aeruginosa
NCT03638830Phase 2Completed
- Start
- Oct 2018
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluorothiazinone in complicated urinary tract infection (cUTI). Started Oct 2018; status: completed.
02
Drugs
Fluorothiazinone
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT03638830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638830.